These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12712240)

  • 1. Nicotinamide: a jack of all trades (but master of none?).
    Szabó C
    Intensive Care Med; 2003 Jun; 29(6):863-866. PubMed ID: 12712240
    [No Abstract]   [Full Text] [Related]  

  • 2. Nicotinamide treatment reduces the levels of oxidative stress, apoptosis, and PARP-1 activity in Aβ(1-42)-induced rat model of Alzheimer's disease.
    Turunc Bayrakdar E; Uyanikgil Y; Kanit L; Koylu E; Yalcin A
    Free Radic Res; 2014 Feb; 48(2):146-58. PubMed ID: 24151909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinamide increases systemic vascular resistance in ovine endotoxemia.
    Scharte M; Nofer JR; Aken HV; Waurick R; Meyer J; Bone HG
    Intensive Care Med; 2003 Jun; 29(6):989-994. PubMed ID: 12728305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The adrenergic coin: perfusion and metabolism.
    Träger K; Radermacher P; Leverve X
    Intensive Care Med; 2003 Feb; 29(2):150-3. PubMed ID: 12594579
    [No Abstract]   [Full Text] [Related]  

  • 5. Nitric oxide synthase inhibition in septic shock--a question of the right time, the right drug, and the right model?
    Bone HG
    Crit Care Med; 1998 Dec; 26(12):1945-7. PubMed ID: 9875895
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of combining nicotinamide as a PARS-inhibitor with selective iNOS blockade during porcine endotoxemia.
    Stehr A; Ploner F; Tugtekin I; Matejovic M; Theisen M; Zülke C; Georgieff M; Radermacher P; Jauch KW
    Intensive Care Med; 2003 Jun; 29(6):995-1002. PubMed ID: 12739012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of poly(ADP-ribose) polymerase inhibitors on some parameters of oxidative stress in blood leukocytes of rats with experimental diabetes].
    Huzyk MM; Diakun KO; Ianits'ka LV; Kuchmerovs'ka TM
    Ukr Biokhim Zh (1999); 2013; 85(1):62-70. PubMed ID: 23534291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of bromobenzene-induced hepatotoxicity by poly(ADP-ribose) polymerase inhibitors.
    Hall KW; Muro-Cacho C; Abritis A; Johnson GT; Harbison RD
    Res Commun Mol Pathol Pharmacol; 2009-2010; 122-123(1-6):79-95. PubMed ID: 22032092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo protective effects of nicotinamide and 3-aminobenzamide on rat synaptosomes treated with Aβ(1-42).
    Bayrakdar ET; Armagan G; Uyanikgil Y; Kanit L; Koylu E; Yalcin A
    Cell Biochem Funct; 2014 Oct; 32(7):557-64. PubMed ID: 25111857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Terlipressin dose response in healthy and endotoxemic sheep: impact on cardiopulmonary performance and global oxygen transport.
    Westphal M; Stubbe H; Sielenkämper AW; Borgulya R; Van Aken H; Ball C; Bone HG
    Intensive Care Med; 2003 Feb; 29(2):301-8. PubMed ID: 12594590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effect of combination of poly (ADP-ribose) polymerase inhibitor and antioxidant in middle cerebral artery occlusion induced focal ischemia in rats.
    Gupta S; Kaul CL; Sharma SS
    Neurol Res; 2004 Jan; 26(1):103-7. PubMed ID: 14977067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotinamide and nicotinamide analogues as antitumor promoters in mouse skin.
    Ludwig A; Dietel M; Schäfer G; Müller K; Hilz H
    Cancer Res; 1990 Apr; 50(8):2470-5. PubMed ID: 2138506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of poly (ADP-ribose) synthetase protect rat proximal tubular cells against oxidant stress.
    Chatterjee PK; Cuzzocrea S; Thiemermann C
    Kidney Int; 1999 Sep; 56(3):973-84. PubMed ID: 10469365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-adrenergic inotropic support in septic shock.
    Domb M; De Boelpaepe C; Vincent JL
    Prog Clin Biol Res; 1987; 236B():319-22. PubMed ID: 3615476
    [No Abstract]   [Full Text] [Related]  

  • 15. [Progress of nicotinamide in preventing infection and sepsis].
    Cheng L; Chen T; Liu Y; Liu K; Liang H
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jul; 32(7):877-879. PubMed ID: 32788029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal models of sepsis.
    Zanotti-Cavazzoni SL; Goldfarb RD
    Crit Care Clin; 2009 Oct; 25(4):703-19, vii-viii. PubMed ID: 19892248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration of diabetes-induced neurobehavioral and neurochemical changes by melatonin and nicotinamide: implication of oxidative stress-PARP pathway.
    Jangra A; Datusalia AK; Khandwe S; Sharma SS
    Pharmacol Biochem Behav; 2013 Dec; 114-115():43-51. PubMed ID: 24201044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(ADP-ribose) synthesis in blocked and damaged cells and its relation to carcinogenesis.
    Boulikas T
    Anticancer Res; 1992; 12(3):885-98. PubMed ID: 1535771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibitors of ADP ribosylation as antiviral agents: an experimental study in a model of HIV infection].
    Krasil'nikov II; Kalnina LB; Korneeva MN; Nosik DN; Zlobin AIu; Vladimirov VG; L'vov DK
    Vopr Virusol; 1991; 36(3):216-8. PubMed ID: 1832508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin synthetase inhibitors in endotoxin or septic shock--a review.
    Fletcher JR
    Adv Shock Res; 1983; 10():9-14. PubMed ID: 6410700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.